Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease

DIANA, ANDREA;SOGOS, VALERIA;
2009-01-01

Abstract

Imbalance of gamma amynobutyric acid (GABA) and related modulators has been indicated as an important factor in the pathogenesis of amyotrophic lateral sclerosis (ALS). In this context, the role and mechanism of action of gabapentin and baclofen (GABA agonistI). This is the first systematic review addressing the benefit of gabapentin or baclofen by means of clinical trials for the treatment of ALS.
2009
1
Sì, ma tipo non specificato
Protocol
Diana, Andrea; Sogos, Valeria; Bongioanni, P; Miller, R; Moore, D.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
5
none
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie